Akt inhibitors in current clinical trials for ovarian cancer treatment (https://clinicaltrials.gov/ct2/results?cond=Ovarian+Cancer+&term=Akt&cntry=&state=& city=&dist=). This evidence concerns the gene AKT1 and ovarian carcinoma.